Anna Terlecka

Anna Terlecka, MBA, is an accomplished Research & Development Director and Board Member at Adamed Pharma, where responsibilities include oversight of research, clinical, registration, and project management since February 2015. Prior experience at Polpharma from June 2007 to January 2015 includes roles such as Head of Analytical Development Department and Head of Validation and Stability Department. Anna Terlecka holds an Executive MBA from Kozminski University and a Master's degree in Biotechnology from Gdańsk University of Technology, along with post-graduate studies in Business Management and Project Management from Uniwersytet WSB Merito Gdańsk.